Humedix, the aesthetics subsidiary of Huons Group, said on the 12th that three products of its hyaluronic acid (HA) filler line "Elravie Plus" received item approval in Syria.
The newly approved products are three types: "Elravie Deep Line Plus 1 ml," "Elravie Ultra Volume Plus 2 ml," and "Elravie Light Plus 1 ml."
Humedix plans to launch these products in the Syrian market in March. To that end, the company will work with Talia Medical LLC, a Syrian importer and distributor of medical devices and beauty products. Based on its local network and understanding of the market, Talia Medical LLC will support a stable supply and smooth market entry for the three Elravie Plus products.
Humedix has already obtained approvals in many countries, including Brazil, China, Iraq, Thailand, and Russia, and is selling Elravie products. With the latest item approval in Syria, the company will make a full-fledged entry into the Middle East market. The company said it plans to accelerate its push into global markets by strengthening its product portfolio and steadily expanding the number of countries where it launches overseas.
Kang Min-jong, CEO of Humedix, said, "The approval in Syria of the three Elravie Plus products will be an important stepping-stone for expanding into global markets," adding, "We plan to continue providing safe and reliable beauty solutions and actively pursue market entry strategies, including in the Middle East."